Recurrent C. difficile Infection: Bacterial Engraftment after Intestinal Microbial Transplant

University of Minnesota
Completed Trials
  • In this trial, researchers monitored stool samples of patients successfully treated with Intestinal Microbiota Transplant capsules for recurrent C. difficile infections over a period of a year. All patients recovered clinically and none had exposure to antibiotics after transplant during the trial period.
  • The majority of patients' microbiota resembled that of the donor throughout the entire period. However, in a quarter of patients the microbiota became entirely different from the donor at one year. In a minority of patients we did not see much in the way of donor microbiota at all.
  • Read the full cited research publication here.